glp 1 agonista Agonistas del receptor de péptido similar al glucagón tipo (GLP-1) en el manejo del paciente con diabetes mellitus tipo 2. Una aproximación para el nefrólogo The Impact of GLP-1 Receptor

Ideal Partner Profiles

In this post, we're diving into an exciting topic that merges science and natural remedies

Ascendis Pharma has granted fellow Denmark-based Novo Nordisk an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk proprietary products in metabolic diseases (including obesity and type 2 diabetes) and a product-by-product exclusive license in cardiovascular diseases.

Clinical studies have shown that semaglutide can lead to significant weight loss when combined with a healthy lifestyle

Sustainable eating habits

And when youre on a GLP-1 receptor agonist, your nutritional strategy is more important than ever